Related references
Note: Only part of the references are listed.Designer nanocarriers for navigating the systemic delivery of oncolytic viruses
Faith Howard et al.
NANOMEDICINE (2020)
Liposomes for Enhanced Cellular Uptake of Anticancer Agents
Gamal M. El Maghraby et al.
CURRENT DRUG DELIVERY (2020)
Oncolytic viruses: overcoming translational challenges
Jordi Martinez-Quintanilla et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells
Lei Wang et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Nanoparticles: Properties and Applications in Cancer Immunotherapy
Alessandra Iscaro et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Perivascular macrophages in health and disease
Antonio Lapenna et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Integrating oncolytic viruses in combination cancer immunotherapy
Praveen K. Bommareddy et al.
NATURE REVIEWS IMMUNOLOGY (2018)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics
Anna Maria Grimaldi et al.
NANOMEDICINE (2017)
Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system
Katsuyuki Aoyama et al.
SCIENTIFIC REPORTS (2017)
Oncolytic Viruses in Cancer Treatment A Review
Sean E. Lawler et al.
JAMA ONCOLOGY (2017)
Oncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy
Jianhua Chen et al.
ACS NANO (2016)
The Multifaceted Role of Perivascular Macrophages in Tumors
Claire E. Lewis et al.
CANCER CELL (2016)
Oncolytic virus therapy: A new era of cancer treatment at dawn
Hiroshi Fukuhara et al.
CANCER SCIENCE (2016)
The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction
Nazanin Hoshyar et al.
NANOMEDICINE (2016)
Harnessing the immune system to improve cancer therapy
Nikos E. Papaioannou et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Russell Hughes et al.
CANCER RESEARCH (2015)
Insights into Chemoresistance of Prostate Cancer
Wei Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Liposomes as nanomedical devices
Giuseppina Bozzuto et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
The evolutionary history of lethal metastatic prostate cancer
Gunes Gundem et al.
NATURE (2015)
A novel immunocompetent murine model for replicating oncolytic adenoviral therapy
L. Zhang et al.
CANCER GENE THERAPY (2015)
Preclinical Safety Assessment of Ad[I/PPT-E1A], a Novel Oncolytic Adenovirus for Prostate Cancer
Ellen Schenk et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2014)
Macrophage Delivery of an Oncolytic Virus Abolishes Tumor Regrowth and Metastasis after Chemotherapy or Irradiation
Munitta Muthana et al.
CANCER RESEARCH (2013)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
Nanoparticles as drug delivery systems
Agnieszka Z. Wilczewska et al.
PHARMACOLOGICAL REPORTS (2012)
Use of Macrophages to Target Therapeutic Adenovirus to Human Prostate Tumors
Munitta Muthana et al.
CANCER RESEARCH (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
Immunotherapy for the treatment of prostate cancer
Giuseppe Di Lorenzo et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Targeted Liposomal Drug Delivery to Monocytes andMacrophages
Ciara Kelly et al.
JOURNAL OF DRUG DELIVERY (2011)
Protective and pathogenic functions of macrophage subsets
Peter J. Murray et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen
Malou Henriksen-Lacey et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Prostate cancer as a model for tumour immunotherapy
Charles G. Drake
NATURE REVIEWS IMMUNOLOGY (2010)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
CCR2 expression correlates with prostate cancer progression
Yi Lu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer
Svend O. Freytag et al.
MOLECULAR THERAPY (2007)
An oncolytic conditionally replicating adenovirus for hormone-dependent and hormone-independent prostate cancer
WS Cheng et al.
CANCER GENE THERAPY (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Hypoxia-induced gene expression in human macrophages - Implications for ischemic tissues and hypoxia-regulated gene therapy
B Burke et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Share Paper
